Ozempic, GLP-1 Drugs, and Your Cycle: Fertility in 2026
GLP-1 drugs like Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) can restore ovulation and fertility indirectly, through weight loss and better insulin sensitivity - the so-called 'Ozempic babies' effect, especially in women with PCOS/PMOS. Two practical points: tirzepatide can reduce oral contraceptive absorption (by up to about 45%), so the FDA advises a backup or non-oral method for 4 weeks after starting and after each dose increase, whereas semaglutide does not have this effect; and GLP-1s are not safe in pregnancy, so manufacturers advise stopping well in advance of conceiving (at least 2 months for semaglutide). If you are on a GLP-1, track your cycle - a returning or regularizing period signals that ovulation may have resumed.

One of the most talked-about side effects of the GLP-1 boom is not on the label: women who were not trying to conceive, and in some cases believed they could not, are getting pregnant. The phenomenon has a nickname - "Ozempic babies" - and it points to something real. These drugs reshape weight, metabolism, and for many women, the menstrual cycle and fertility.
A December 2025 review in the Annals of Medicine and Surgery on GLP-1 drugs and preconception planning laid out what clinicians are now seeing: restored ovulation, possible interactions with the pill, and important questions about pregnancy safety. As prescriptions keep climbing into 2026, this has become essential knowledge for anyone who menstruates.
If you are on a GLP-1 - or thinking about one - here is what it can mean for your cycle.
What GLP-1 drugs actually are
GLP-1 receptor agonists mimic a gut hormone that controls blood sugar and appetite. They slow how fast your stomach empties, increase fullness, and improve how your body handles insulin. The result, for many people, is significant weight loss.
The names you will recognize:
- Semaglutide - sold as Ozempic (for type 2 diabetes) and Wegovy (for weight loss)
- Tirzepatide - a dual GIP/GLP-1 drug sold as Mounjaro and Zepbound
- Newer oral versions are arriving, widening access further
These are powerful metabolic drugs - and metabolism and the reproductive system are tightly linked, which is exactly why periods and fertility can shift.
The problem this affects: weight, PCOS, and ovulation
Body weight and insulin resistance have a strong influence on the menstrual cycle. Carrying excess weight, and the insulin resistance that often comes with it, can disrupt ovulation - which is a core feature of PCOS, now increasingly called PMOS. Irregular or absent ovulation is one of the most common reasons periods become unpredictable and conception becomes harder.
When a GLP-1 drives weight loss and improves insulin sensitivity, it can reverse that disruption - and ovulation can come back, sometimes quickly and without warning.
What the research shows
Ovulation can return - hence "Ozempic babies"
For women with PCOS/PMOS or weight-related cycle problems, the metabolic improvement from a GLP-1 can restart ovulation and regular periods. Crucially, the drug is not a fertility treatment - the fertility boost is an indirect effect of weight loss and better metabolic health. But the practical result is the same: women who assumed they were infertile or "safe" can suddenly ovulate again and conceive.
Birth control can become less reliable - but it depends on the drug
This is the part many women are not warned about, and the two main drugs behave differently:
- Tirzepatide (Mounjaro/Zepbound) can reduce the absorption of oral contraceptives - by up to around 45% in studies - because it slows stomach emptying. The FDA label advises using a backup or non-oral method (such as condoms) for 4 weeks after starting and for 4 weeks after each dose increase.
- Semaglutide (Ozempic/Wegovy) has not been shown to meaningfully reduce oral contraceptive levels.
So if you are on tirzepatide and rely on the pill, you may be less protected than you think during the start-up and dose-increase windows.
These drugs are not safe in pregnancy
GLP-1 drugs are not recommended during pregnancy. Animal studies show potential harm and there is not enough human safety data. Because the drugs clear the body slowly, manufacturers advise stopping well before trying to conceive - for semaglutide, at least 2 months ahead - and discussing the timing with your prescriber. If you become pregnant unexpectedly while taking one, contact your clinician promptly.
What this means for you
Two messages matter most. First, if you do not want to get pregnant on a GLP-1, do not assume your old cycle still applies - ovulation may return, and if you are on tirzepatide your pill may be less reliable at the start. Use reliable contraception and a backup where advised. Second, if you do want to conceive, a GLP-1 may help by restoring ovulation, but you will likely need to stop it before trying and plan the timing with your clinician.
Signs your cycle is changing on a GLP-1
Watch for:
- Periods returning after a long absence, or becoming more regular
- Ovulation signs you had not noticed before - mid-cycle ovulation symptoms like egg-white cervical mucus, a mild one-sided twinge, or a small rise in basal body temperature
- A more predictable cycle length month to month
- For some, changes in flow as cycles normalize
These are signs that ovulation may have resumed - which is good news if you are trying, and a reason to tighten up contraception if you are not.
What to do
- Track your cycle from the day you start. A returning or regularizing period is the clearest sign your fertility may be changing.
- If you are on tirzepatide and use the pill, add a backup method for the first 4 weeks and after every dose increase, or ask about a non-oral method.
- If you want to conceive, talk to your prescriber about when to stop the drug before trying - the washout matters because GLP-1s are not used in pregnancy.
- If you could get pregnant and do not want to, use reliable contraception and do not rely on a past history of irregular cycles.
- Confirm a pregnancy early if your period is late, and contact your clinician about stopping the medication safely.
- Bring your tracked cycle data to appointments - it shows whether ovulation has resumed.
How Femora helps
A GLP-1 can change your fertility silently, and the first visible sign is in your cycle - which is exactly what a tracker captures.
With Femora you can:
- Log your periods and ovulation signs so a returning or regularizing cycle is obvious, whether you are trying to conceive or trying to avoid it.
- Predict your fertile window with the ovulation calculator and fertile window calculator, and estimate timing with the conception date calculator if you are planning a pregnancy.
- Plan contraception around dose changes by seeing where you are in your cycle during the higher-risk start-up and dose-increase windows.
If you are weighing up the pill alongside a GLP-1, our guide to birth control and cycle tracking covers how to combine the two.
The bigger picture
GLP-1 drugs were designed for blood sugar and weight, but they have quietly become a women's health story. By shifting weight and insulin, they can switch ovulation back on - restoring fertility for some women and catching others off guard. The drugs themselves do not know your intentions; your cycle is where their effects show up first. Tracking it is how you stay in control of what happens next.
Track your cycle, ovulation, and fertile window with Femora. Free on iOS and Android. If a GLP-1 is changing your fertility, your cycle data will show it first.
Sources
- GLP-1 receptor agonists and preconception planning - Annals of Medicine and Surgery, 2025-12.
- Is there really an Ozempic baby boom? The unexpected ways GLP-1s could influence fertility - National Geographic, 2024.
- Ozempic Babies? What Research Says About Semaglutide & Fertility - GoodRx Health, 2025.
- Semaglutide - NHS, 2024.